Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The inferior vena cava is a large, retroperitoneal vein that collects deoxygenated blood from the lower half of the body—including the lower limbs, pelvis, and abdomen—and delivers it to the right atrium of the heart[1][4][6]. It is formed by the confluence of the right and left common iliac veins at the level of the fifth lumbar vertebra, ascends on the right side of the vertebral column, and enters the right atrium through the diaphragm[1][3][5]. The IVC is the largest vein in the human body and essential for venous return from the lower body. Clinical issues related to the IVC include thrombosis, compression by tumors or the uterus, and trauma, but it is not a molecular, cellular, or protein therapeutic target—it is a macroscopic anatomical structure[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inferior vena cava (IVC).